понедельник, 26 декабря 2016 г.

Vertex Pharmaceuticals Inc. (VRTX) Raised to "Strong-Buy" at Vetr Inc.

Vertex Pharmaceuticals Inc. (VRTX) Raised to "Strong-Buy" at Vetr Inc.


The firm presently has a $94.50 price target on the pharmaceutical company's stock. Vetr 's target price would indicate a potential upside of 27.17% from the company's previous close.



from Biotech News